Filtered Image?height=270

News & Publications

News & insights

AI and the use of data in the life sciences sector
Posted: 24/06/2024
AI is having a major impact on life sciences. Its ability to process vast quantities of data and information faster than humans has numerous valuable applications in the sector, from creating new drugs and targets, to use in medical devices to diagnose disease, as well as monitoring patients remotely, and analysing data, for example from MRI......>>
Generative AI in the courts: Getty Images v Stability AI
Posted: 16/02/2024
In January 2023, Getty Images – a ‘pre-eminent global visual content creator and market place’ – commenced legal proceedings in the English High Court against Stability AI, an open-source generative artificial intelligence (AI) company. Getty is alleging infringement of its IP rights in relation to Stability’s deep learning AI model that automatically......>>
Supreme Court rules that AI system cannot be named as inventor on UK patent
Posted: 10/01/2024
After four years of legal proceedings the UK Supreme Court has now finally settled the question of whether an AI system can be an inventor on a UK patent. In Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49, the court decided that a patent application which names an AI system as the inventor cannot proceed......>>
New address for service requirements at the UKIPO affecting comparable (clone) UK trade marks and re-registered designs - effective 1 January 2024
Posted: 01/12/2023
As of 1 January 2024, the UK Intellectual Property Office (UKIPO) is changing its rules concerning addresses for service for certain proceedings affecting United Kingdom trade marks and designs. This important development affects EU/EEA owners and representatives of UK comparable trade marks and re-registered designs (‘cloned rights’)......>>
Associated Press and Open AI: the first news-sharing and technology partnership
Posted: 26/10/2023
The two-year partnership between the Associated Press (AP) and OpenAI, the parent company of ChatGPT, is one that has the potential to influence the way developers access and exploit valuable data sets to train AI. Whilst some of the key details of the deal have not been disclosed, including the commercial terms, what has been shared is that......>>

Read all Intellectual property news & insights

Publications

E-Bulletins

BioBrief - August 2023
In this edition of BioBrief, we look in detail at a recent case involving university-generated intellectual property and in particular the position of students who contribute to such IP. On a related topic, I give some practical, high-level guidance on the legal position relating to the ownership of inventions when outside consultants are involved.

BioBrief - April 2023
Following recent shockwaves throughout the sector caused by the demise of SVB, in this month’s BioBrief, we provide a link to a timely discussion of the funding options for early stage life sciences companies, published by our friends at OBN.

BioBrief - November 2022
A key strategic issue for many seeking partnerships with Big Pharma or other sources of funding is the robustness of the patent portfolio. IP issues feature in two contributions to this month’s BioBrief: in the first, my colleague Dr Amanda Easey and I present a videocast on the recent decision of the Patents Court.

BioBrief - May 2022
Welcome to the spring edition of BioBrief. We start this edition with an article I wrote recently for OBN Connect magazine which covers the challenges faced by Biotech founders on spin-out and the career change it requires. This is something that I am familiar with as I changed my career from project manager of global clinical trials for IQVIA to being an IP lawyer.

BioBrief - Winter 2021
Welcome to the winter edition of BioBrief. It has certainly been a very busy year for the life sciences industry! Colleagues across our team have been involved in interesting projects, in particular in terms of commercial deals and corporate transactions. We are delighted to report that, amongst others, we advised the shareholders of molecular diagnostics company ATDBio on its sale to NASDAQ Stockholm listed Biotage AB for approximately £45m..

View all intellectual property e-bulletins

Return to Intellectual property

Filter publications

Filter by keyword: Filter by expertise: Filter by publication type:

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Value

Contact an office

London (Head office)
+44 (0)20 7457 3000
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2024 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority under number 419867.